• Hypoxia and Immunometabolism: Mechanisms in Tumor Progressio

  2026-05-28

  This review elucidates how hypoxia-driven metabolic reprogramming and immune cell adaptations shape the immunosuppressive tumor microenvironment (TME), directly influencing tumor proliferation and immune evasion. It systematically unpacks the interplay between oxygen deprivation, altered glucose metabolism, and immune modulation, highlighting implications for metabolism-based cancer therapies.

• ERK5 and ERK1/2 Pathways in Vitamin D3-Induced AML Different

  2026-05-28

  This study demonstrates that the ERK5/MAPK pathway plays a critical and distinct role in terminal differentiation of myeloid leukemia cells induced by 1α,25-(OH)2 vitamin D3. By dissecting the effects of selective inhibition of ERK5 versus ERK1/2, the research uncovers divergent impacts on differentiation markers and cell cycle progression, offering new perspectives for targeted leukemia therapies.

• Shh, Fgf10, and Fgfr2 Differential Expression in Penile Morp

  2026-05-27

  This study reveals that species-specific differences in prepuce and urethral groove formation between guinea pigs and mice are controlled by distinct expression patterns of Shh, Fgf10, and Fgfr2. The findings refine models of mammalian penile development and inform future research directions in developmental biology and congenital anomalies.

• YC-1: Unraveling HIF-1α Inhibition and Mitochondrial Protect

  2026-05-27

  Explore the multifaceted research value of YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol as a potent tool for HIF-1α inhibition and mitochondrial quality control. This article offers unique insights into its role in apoptosis, tumor angiogenesis, and neuroprotection, drawing on recent mechanistic advances and practical assay guidance.

• FH1 Small Molecule: Precision Tools for Hepatocyte Function

  2026-05-26

  Explore how FH1, a small molecule from APExBIO, advances cultured hepatocyte function by driving iPS cell differentiation and functional maturation. This article uniquely bridges fundamental mechanisms to translational assay design, highlighting key innovations for liver research.

• Cell Death Responses in Liver Disease: Mechanisms and Clinic

  2026-05-26

  This review elucidates how distinct modes of hepatocyte death—apoptosis, necrosis, and necroptosis—drive the progression of liver diseases such as fibrosis, cirrhosis, and hepatocellular carcinoma. The paper highlights the clinical relevance of cell death biomarkers and discusses the stage- and cell-type specificity of death pathways, offering a foundation for targeted experimental modeling and therapeutic exploration.

• Tin Mesoporphyrin IX (chloride): Precision Inhibition for He

  2026-05-25

  Tin Mesoporphyrin IX (chloride) delivers nanomolar inhibition of heme oxygenase, enabling unparalleled sensitivity for dissecting heme catabolism in metabolic, virology, and redox research settings. Its robust in vivo performance and application flexibility make it an essential tool for experimental workflows where precise modulation of HO activity is critical.

• Poly (I:C): Synthetic dsRNA Analog for Robust Immune Activat

  2026-05-25

  Poly (I:C), a synthetic double-stranded RNA analog, is a gold-standard tool for mimicking viral infection and driving potent innate immune responses in experimental systems. This article translates advanced insights into actionable workflows, troubleshooting, and practical innovations for maximizing assay performance with APExBIO's Poly (I:C).

• Dasatinib (BMS-354825): Strategic Kinase Inhibition in Trans

  2026-05-24

  This article synthesizes mechanistic insights and strategic guidance on leveraging Dasatinib (BMS-354825) in translational cancer research. By integrating findings from recent multi-omics studies—especially the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors (TETs)—with practical recommendations and competitive context, it provides actionable direction for researchers seeking to advance kinase-targeted workflows. The discussion highlights the unique advantages of APExBIO's Dasatinib and situates its use within the broader evolution of experimental oncology.

• PK/PD of Gamithromycin for Pasteurella multocida in Mice

  2026-05-23

  This study establishes the pharmacokinetic/pharmacodynamic (PK/PD) relationship of Gamithromycin for treating Pasteurella multocida lung infections in a neutropenic murine model. The findings provide actionable PK/PD indices that enable optimized dosing regimens and inform translational research in veterinary medicine.

• 3X (DYKDDDDK) Peptide: Advanced Tagging for Protein Purifica

  2026-05-22

  The 3X (DYKDDDDK) Peptide offers unmatched sensitivity for affinity purification and immunodetection of FLAG-tagged proteins, outperforming traditional tags in challenging workflows. Its unique trimeric structure and metal-binding properties set new standards for reproducibility and versatility in recombinant protein studies.

• Nuclear cGAS Restricts L1 Retrotransposition via TRIM41-ORF2

  2026-05-22

  This study uncovers a pivotal nuclear function of cGAS in preserving genome stability by repressing LINE-1 (L1) retrotransposition through TRIM41-mediated degradation of ORF2p. The findings clarify posttranslational control mechanisms of L1 and highlight new intersections between innate immunity, DNA damage response, and cancer biology.

• SD 169 (indole-5-carboxamide): Unraveling Dual-Action p38 MA

  2026-05-21

  Explore how SD 169 (indole-5-carboxamide) uniquely enables dual modulation of p38 MAPK signaling and phosphatase-driven dephosphorylation, advancing both type 1 diabetes and axonal regeneration research. This article offers a deeper scientific lens on conformational control and translational workflows.

• Cy3-UTP for Quantitative RNA Imaging and Trafficking Studies

  2026-05-21

  Cy3-UTP, a Cy3-modified uridine triphosphate from APExBIO, unlocks high-sensitivity RNA labeling for advanced fluorescence imaging and RNA-protein interaction research. This guide demystifies optimized workflows, troubleshooting, and leverages insights from cutting-edge studies to maximize assay robustness and intracellular trafficking analysis.

• Cy3-UTP: Optimizing Fluorescent RNA Labeling for Advanced As

  2026-05-20

  Cy3-UTP empowers researchers with high-brightness, photostable RNA labeling, enabling precise visualization of RNA trafficking and interactions. This guide translates recent endosomal trafficking research into actionable protocols and troubleshooting insights, maximizing assay sensitivity and reliability for RNA biology applications.

721 records 14/49 page Previous Next First page 上5页 1112131415 下5页 Last page